Thus, CuS NPs loaded with an FSP1 inhibitor disrupt 2 complementary redox defense pathways and, in synergy with NIR irradiation, potentiate ICD
a growth hormone-releasing factor analog, is FDA-approved for the treatment of HIV-associated lipodystrophy , with studies showing significant reduction in visceral adipose tissue (VAT) after 26 weeks of useSource: Falutz et al., New England Journal of Medicine, 2010
Healing is a holistic process
The Dual Face of 5-Alpha Reductase 5-alpha reductase is not simply a hair loss enzyme. It is a steroid-metabolizing enzyme involved in androgen, estrogen, bile acid, and glucocorticoid metabolism
Panel B: In a post-translational modification called 4-pantetheinylation, the enzyme 4-phosphopantetheinyl transferase catalyzes the hydrolysis of coenzyme A into 3,5-adenosine diphosphate and 4-phosphopantetheine and the transfer of the 4-phosphopantetheinyl moiety to a specific serine residue of FDH